News

No link between head and neck cancers and marijuana use


 

FROM ARCHIVES OF ORAL BIOLOGY

References

Marijuana use does not seem to be a risk factor for head and neck cancer (HNC) suggests a meta-analysis including nine case-control studies.

Smithore

The chance of developing head and neck cancer in individuals who had smoked marijuana in their lifetime was estimated using an odds ratio, and controlling for age, sex, race, and tobacco consumption.

Approximately 12.6% of the patients who developed HNC and 14.3% of the controls were marijuana users. No association was found between exposure to marijuana and HNC (odds ratio = 1.021).

“Despite several inferences that have made to date, there is currently insufficient epidemiological evidence to support a positive or negative association in marijuana use and the development of HNC,” the researchers said.

Future studies on the long-term effects of marijuana use and “the mechanism of action of cannabinoids in specific tissues in animal models and humans” are needed, according to the researchers.

Read the full study in Archives of Oral Biology (doi: 10.1016/j.archoralbi.2015.09.009).

klennon@frontlinemedcom.com

Recommended Reading

Postdiagnosis imaging increasing for patients with all stages of thyroid cancer
MDedge Internal Medicine
Study aims to determine prognostic factors for subset of thyroid cancer patients
MDedge Internal Medicine
Lenvima gets the FDA’s nod for differentiated thyroid cancer
MDedge Internal Medicine
Most thyroid nodules have favorable prognosis
MDedge Internal Medicine
VIDEO: Meet Frankie and Sophie, the thyroid cancer–sniffing dogs
MDedge Internal Medicine
Oral cancer survival lower with positive margins, public insurance
MDedge Internal Medicine
Thyroid cancer outcomes worse for black and Hispanic young adults
MDedge Internal Medicine
RAI given to thyroid CA patients does not increase their breast malignancy occurrence, recurrence
MDedge Internal Medicine
Moderate THST was most effective at treating thyroid cancer
MDedge Internal Medicine
Persistent HPV16 DNA in oral rinse signaled oropharyngeal cancer’s return
MDedge Internal Medicine